![](https://img.einpresswire.com/small/157124/montis-logo.png)
Montis Biosciences appoints Karen Zinkewich-Péotti as Chief Executive Officer
Dr. Karen Zinkewich-Péotti brings brings strong R&D leadership experience from both international biopharmaceutical companies and smaller biotech. LEUVEN, BELGIUM, September 29, 2020 /EINPresswire.com/ -- MONTIS BIOSCIENCES, a discovery stage biotech company focused on novel immuno-oncology therapeutics targeting the interactions between perivascular macrophages and the tumor vasculature, has named Karen Zinkewich-Péotti, Ph.D., as its Chief Executive Officer. Dr. Zinkewich-Péotti brings strong R…